Another group of researchers investigated oncogenic markers, such as the TP53 mutation, and implemented an algorithm pipeline consisting of 10 variables to stratify TP53-mutated DLBCL using mutation class, VAF, and structure [72]. This evidence concerns the gene TP53 and diffuse large B-cell lymphoma.